Table of Contents Author Guidelines Submit a Manuscript
Psychiatry Journal
Volume 2014, Article ID 136158, 4 pages
http://dx.doi.org/10.1155/2014/136158
Research Article

Adverse Effects of Risperidone in Children with Autism Spectrum Disorders in a Naturalistic Clinical Setting at Siriraj Hospital, Thailand

Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Prannok Road, Bangkok 10700, Thailand

Received 2 October 2013; Revised 4 December 2013; Accepted 20 December 2013; Published 3 February 2014

Academic Editor: Michael Fitzgerald

Copyright © 2014 Vitharon Boon-yasidhi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. R. Volkmar, C. Lord, A. Bailey, R. T. Schultz, and A. Klin, “Autism and pervasive developmental disorders,” Journal of Child Psychology and Psychiatry and Allied Disciplines, vol. 45, no. 1, pp. 135–170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Kaplan and J. T. McCracken, “Psychopharmacology of autism spectrum disorders,” Pediatric Clinics of North America, vol. 59, no. 1, pp. 175–187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Posey and C. J. McDougle, “Pharmacotherapeutic management of autism,” Expert Opinion on Pharmacotherapy, vol. 2, no. 4, pp. 587–600, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Nazeer, “Psychopharmacology of autistic spectrum disorders in children and adolescents,” Pediatric Clinics of North America, vol. 58, no. 1, pp. 85–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Nicolson, G. Awad, and L. Sloman, “An open trial of risperidone in young autistic children,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 37, no. 4, pp. 372–376, 1998. View at Google Scholar · View at Scopus
  6. F. Vercellino, E. Zanotto, G. Ravera, and E. Veneselli, “Open-label risperidone treatment of 6 children and adolescents with autism,” Canadian Journal of Psychiatry, vol. 46, no. 6, pp. 559–560, 2001. View at Google Scholar · View at Scopus
  7. G. Masi, A. Cosenza, M. Mucci, and G. de Vito, “Risperidone monotherapy in preschool children with pervasive developmental disorders,” Journal of Child Neurology, vol. 16, no. 6, pp. 395–400, 2001. View at Google Scholar · View at Scopus
  8. V. Boon-Yasidhi, C. Suwanwattana, J. Tarugsa, and L. Soising, “Risperidone in the treatment of autistic Thai children under 4 years of age,” Journal of the Medical Association of Thailand, vol. 85, supplement 2, pp. S784–S789, 2002. View at Google Scholar · View at Scopus
  9. J. T. McCracken, J. McGough, B. Shah et al., “Risperidone in children with autism and serious behavioral problems,” The New England Journal of Medicine, vol. 347, no. 5, pp. 314–321, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Shea, A. Turgay, A. Carroll et al., “Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders,” Pediatrics, vol. 114, no. 5, pp. e634–e641, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. “Risperdal (risperidone): US prescribing information,” 2009, http://www.risperdal.com/risperdal/shared/pi/risperdal.pdf.
  12. M. G. Aman, L. E. Arnold, C. J. McDougle et al., “Acute and long-term safety and tolerability of risperidone in children with autism,” Journal of Child and Adolescent Psychopharmacology, vol. 15, no. 6, pp. 869–884, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Kwon, “Tardive dyskinesia in an autistic patient treated with risperidone,” The American Journal of Psychiatry, vol. 161, no. 4, pp. 757–758, 2004. View at Google Scholar · View at Scopus
  14. V. J. Fedorowicz and E. Fombonne, “Metabolic side effects of atypical antipsychotics in children: a literature review,” Journal of Psychopharmacology, vol. 19, no. 5, pp. 533–550, 2005. View at Publisher · View at Google Scholar · View at Scopus